Log in to save to my catalogue

Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in...

Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4de5c34119a84c76a1d7d518f7d3d43d

Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom

About this item

Full title

Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom

Publisher

England: BioMed Central Ltd

Journal title

Allergy, asthma, and clinical immunology, 2018-08, Vol.14 (1), p.28-28, Article 28

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Hereditary angioedema (HAE) is a potentially life-threatening, bradykinin-mediated disease, often misdiagnosed and under-treated, with long diagnostic delays. There are limited real-world data on best-practice management of HAE in the UK.
To characterize the clinical profile, management and outcomes of patients with HAE type I and II from three...

Alternative Titles

Full title

Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4de5c34119a84c76a1d7d518f7d3d43d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4de5c34119a84c76a1d7d518f7d3d43d

Other Identifiers

ISSN

1710-1484,1710-1492

E-ISSN

1710-1492

DOI

10.1186/s13223-018-0253-x

How to access this item